A carregar...
EphB4 as a therapeutic target in mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) often develops decades following exposure to asbestos. Current best therapy produces a response in only half of patients, and the median survival with this therapy remains under a year. A search for novel targets and therapeutics is underway, and rece...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3671960/ https://ncbi.nlm.nih.gov/pubmed/23721559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-269 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|